Ready-to-use (RTU) container technology is helping pharmaceutical manufacturers improve efficiency, flexibility and contamination control in parenteral manufacturing.
By eliminating the need for in-house container washing, sterilisation and depyrogenation, RTU formats can reduce preparation time, simplify line changeovers and lower equipment requirements. Standardised vials, syringes and cartridges also support multi-format production, making them particularly valuable for small-batch medicines, biologics and advanced therapy medicinal products (ATMPs).
The technology can further support contamination control strategies by reducing operator intervention and providing pre-sterilised containers that remain sealed until use. However, manufacturers must still assess the risks associated with the transport and handling of containers sterilised off-site.
As RTU technology advances, improvements in automation, container design and high-speed filling are expected to support greater productivity and the growing demand for flexible pharmaceutical manufacturing.
Read the full article: Advancing parenteral manufacturing: the role of the RTU container
